Agewall Stefan Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Astra Zeneca : Platelet inhibition
Bassand Jean-Pierre Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Glaxo Smith Kline : fondaparinux - Lilly : prasugrel
- Astra Zeneca : ticagrelor
Bax Jeroen Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Heart.org : Education - Astra Zeneca : Farma
- Servier : Farma
- Philips : Imaging
- GE Healthcare : Imaging
- Lantheus : Imaging
- Boston Scientific : Pacing
- Medtronic : Pacing
- St Jude Medical : Pacing
- Biotronik : Pacing
- Impulse Dynamics : Pacing
D - Research funding (departmental or institutional). - Servier : Farma - Edwards Lifesciences : Heart Valves
- GE Healthcare : Imaging
- Lantheus : Imaging
- Boston Scientific : Pacing
- Medtronic : Pacing
- St Jude Medical : Pacing
Guidelines on ACS-NSTE (TF21) - Task Force Members and Additional Contributors
Expert Relationship with Industry
Type of relationship with industry Financial declaration
Bax Jeroen Yes - Biotronik : Pacing
Boersma Eric Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Medtronic : coronary artery disease
Bueno Hector Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Bayer Healthcare : Aspirin - Merck, Schering Plough : None
- Daiichi Sankyo : Prasugrel
- Eli Lilly : Prasugrel
- Astra Zeneca : Ticagrelor
Caso Pio Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Consorzio formazione medica : lessons C - Receipt of royalties for intellectual property. - piccin nuova libraria spa : book
Dudek Dariusz Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Boehringer-Ingelheim : speaker fee, advisory boards, investigator. - Boston Scientific : speaker fee, advisory boards, investigator.
- Eli Lilly : speaker fee, advisory boards, investigator.
- Pfizer : speaker fee, advisory boards, investigator.
- Sanofi Aventis : speaker fee, advisory boards, investigator.
- Siemens Healthcare : speaker fee, advisory boards, investigator.
- GlaxoSmithKline : speaker fee, advisory boards, investigator.
- Bayer Healthcare : speaker fee, advisory boards, investigator.
- Cook Medical : speaker fee, advisory boards, investigator.
- Medicines Company : speaker fee, advisory boards, investigator.
- Nycomed : speaker fee, advisory boards, investigator.
- Bristol Myers Squibb : speaker fee, advisory boards, investigator.
- MSD : speaker fee, advisory boards, investigator.
Guidelines on ACS-NSTE (TF21) - Task Force Members and Additional Contributors
Expert Relationship with Industry
Type of relationship with industry Financial declaration
Dudek Dariusz Yes - Balton : speaker fee, advisory boards, investigator.
- Cordis : speaker fee, advisory boards, investigator.
- Biotronic : speaker fee, advisory boards, investigator.
- Solvay : speaker fee, advisory boards, investigator.
- BBraun : speaker fee, advisory boards, investigator.
- EuroCor : speaker fee, advisory boards, investigator.
- INvatec : speaker fee, advisory boards, investigator.
- Medtor : speaker fee, advisory boards, investigator.
- Promed : speaker fee, advisory boards, investigator.
- Therumo : speaker fee, advisory boards, investigator.
- Tyco : speaker fee, advisory boards, investigator.
E - Research funding (personal). - Abbott : speaker fee, advisory boards, investigator. - Adamed : speaker fee, advisory boards, investigator.
- Astra Zeneca : speaker fee, advisory boards, investigator.
- Boehringer-Ingelheim : speaker fee, advisory boards, investigator.
- Boston Scientific : speaker fee, advisory boards, investigator.
- Eli Lilly : speaker fee, advisory boards, investigator.
- Medtronic : speaker fee, advisory boards, investigator.
- Pfizer : speaker fee, advisory boards, investigator.
- Biotronik : speaker fee, advisory boards, investigator.
- Terumo Inc : speaker fee, advisory boards, investigator.
- Sanofi Aventis : speaker fee, advisory boards, investigator.
- Siemens Healthcare : speaker fee, advisory boards, investigator.
- GlaxoSmithKline : speaker fee, advisory boards, investigator.
Guidelines on ACS-NSTE (TF21) - Task Force Members and Additional Contributors
Expert Relationship with Industry
Type of relationship with industry Financial declaration
Dudek Dariusz Yes - Bayer Healthcare : speaker fee, advisory boards, investigator.
- Cook Medical : speaker fee, advisory boards, investigator.
- Nycomed : speaker fee, advisory boards, investigator.
- MSD : speaker fee, advisory boards, investigator.
- Balton : speaker fee, advisory boards, investigator.
- Cordis : speaker fee, advisory boards, investigator.
- Solvay : speaker fee, advisory boards, investigator.
- BBraun : speaker fee, advisory boards, investigator.
- EuroCor : speaker fee, advisory boards, investigator.
- INvatec : speaker fee, advisory boards, investigator.
- Promed : speaker fee, advisory boards, investigator.
- Tyco : speaker fee, advisory boards, investigator.
- Biomatrix : speaker fee, advisory boards, investigator.
- Mediciine Company : speaker fee, advisory boards, investigator.
Gielen Stephan Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Genzyme : Lecture on genetic cardiac diseases incl. M. Fabry, 1000 € honorarium - Astra zeneca, boheringer, menarini : Product-independent cardiology case workshop twice a year, honorarium 1.100 € per event
Hamm Christian Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Merck : drugs - Pfizer : drugs
- Sanofi-Aventis : drugs
- The Medicines Company : drugs
- Menarini : drugs
- Daiichi-Sankyo : drugs
- Berlin Chemie AG : drugs
Guidelines on ACS-NSTE (TF21) - Task Force Members and Additional Contributors
Expert Relationship with Industry
Type of relationship with industry Financial declaration
Hamm Christian Yes - Heart.org : drugs
- Boehringer Ingelheim - Ingelheim; Daiichi-Sankyo/Eli Lilly; Nycomed Pharma : drugs
- Takeda Pharmaceuticals : drugs
- Glaxo Smith Kline : drugs
- Astra Zeneca, Bayer AG, Boehringer-Ingelheim, Daiichi-Sankyo, MSD, Novartis, Pfizer, Sanofi-Aventis, Servier : drugs
- BRAHMS GmbH : markers
- Siemens Healthcare : MRI
- Boston Scientific : PCI
- Cordis and Medtronic : PCI
Huber Kurt Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Pfizer - speakers fees : atorvastatin - The Medicines Company - speakers fees : bivalirudin; cangrelor
- BRAHMS GmbH - speakers fees : copeptin assay
- Boehringer Ingelheim - speakres fees; advisory board fees (dabigatran) : dabigatran
- Boston Scientific - speakres fees : none
- Biotronik - speakers fees : none
- Eli Lilly Lilly/Daiichi Sankyo - speakers fees; advisory board fees (prasugrel) : prasugrel; abciximab
- Bayer - speaker fees; advisory board fees (rivaroxaban) : rivaroxaban
- Astra Zeneca - speakers fees; advisory board fees (ticagrelor) : ticagrelor; rosuvastatin
Ohman E Magnus Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Liposcience : Diagnostic tests - WebMD : Online health information provider
- Astra Zeneca : Pharmaceuticals
- Boehringer-Ingelheim : Pharmaceuticals
- The Medicines Company : Pharmaceuticals
Guidelines on ACS-NSTE (TF21) - Task Force Members and Additional Contributors
Expert Relationship with Industry
Type of relationship with industry Financial declaration
Ohman E Magnus Yes - Sanofi Aventis : Pharmaceuticals
- Bristol Myers Squibb : Pharmaceuticals
- Merck Sharp & Dohme : Pharmaceuticals
- Gilead Sciences : Pharmaceuticals
- Pozen, Inc. : Pharmaceuticals
B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Daiichi Sankyo : Pharmaceuticals - Eli Lilly : Pharmaceuticals
D - Research funding (departmental or institutional). - Maquet : Medical technology/products - Daiichi Sankyo : Pharmaceuticals
- Eli Lilly : Pharmaceuticals
Petrie Mark Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Roche : diabetes - GSK : diabetes
- Astellas : diabetes
- Servier : heart failure
Sonntag Frank Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Servier : CAD - Sanofii-Aventis : CAD
- Bayer Healthcare : CAD
- Merck Sharp & Dome : CAD
- Boehringer Ingelheim - : CAD
- Astra Zeneca : CAD,Plateletaggregationinhibitor
Sousa Uva Miguel Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Medtronic : TAVI
Guidelines on ACS-NSTE (TF21) - Task Force Members and Additional Contributors
Expert Relationship with Industry
Type of relationship with industry Financial declaration
Sousa Uva Miguel Yes B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Lilly : Antiplatelet agent
Storey Robert Frederick Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - The Medicines Company : Cangrelor - Sanofi Aventis : Clopidogrel
- Bristol Myers Squibb : Clopidogrel
- Novartis : Elinogrel
- GlaxoSmithKline : Fondaparinux
- Eli Lilly Lilly/Daiichi Sankyo - speakers fees; advisory board fees (prasugrel) : Prasugrel
- Astra Zeneca : Ticagrelor
- Merck : Vorapaxar
B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Astra Zeneca : Ticagrelor - Accumetrics : VerifyNow
D - Research funding (departmental or institutional). - Daiichi Sankyo : Prasugrel - Eli Lilly : Prasugrel
- Astra Zeneca : Ticagrelor
- Merck : Vorapaxar
Wijns William Yes B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Boston Scientific : device - Edwards Lifesciences : device
- Terumo Inc : device
- Cordis : device
- Orbus Neich : device
- Astra Zeneca : drug
Guidelines on ACS-NSTE (TF21) - Task Force Members and Additional Contributors
Expert Relationship with Industry
Type of relationship with industry Financial declaration
Wijns William Yes - Eli Lilly : drug
- GlaxoSmithKline : drug
- Bristol Myers Squibb : drug
D - Research funding (departmental or institutional). - Cardio3 Biosciences : cell therapy - Boston Scientific : device
- Medtronic : device
- St Jude Medical : device
- Abbott Laboratories : device
- Biotronic : device
- Therabel : drug
- Ablynx : nano antibodies
Zahger Doron Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Sanofi Aventis : Dronedarone - Pfizer : lipitor
- Eli Lilly : prasugrel
- Astra zeneca, boheringer, menarini : Ticagrelor
Guidelines on ACS-NSTE (TF21) - TF Members and Additional Contributors
Expert Relationship with Industry
Type of relationship with industry Financial declaration
Achenbach Stephan Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Siemens Healthcare : CT - Servier : Imaging
- Guerbet : Imaging
D - Research funding (departmental or institutional). - Siemens Healthcare : Imaging - Bayer Healthcare : Imaging
Badimon Lina Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Astra Zeneca : cardiovascular - Menarini : cardiovascular
- Esteve : Cardiovascular
Bertrand Michel Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Lilly : Anticoagulants - Servier International : Antihypertensive drugs. Antiischemic drugs
Botker Hans Erik Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Astra Zeneca - speaker fee : Hyperlipidema, angina pectoris
Collet Jean-Philippe Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Bristol Myers Squibb : apixaban - Nycomed : aspirin
- Sanofi Aventis : clopidogrel
- Roche Diagnostics : hypersensitive troponin
- Astra Zeneca : prasugrel
- Eli Lilly : prasugrel
D - Research funding (departmental or institutional). - Sanofi-Aventis : clopidogrel - Cordis and Medtronic : platelet function testing
Crea Filippo Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Pfizer - speakers fees : Atorvastatin
Guidelines on ACS-NSTE (TF21) - Document Reviewers
Expert Relationship with Industry
Type of relationship with industry Financial declaration
Crea Filippo Yes - Boehringer Ingelheim-Advisory Board : Dabigatran
- GSK : Darapladip
- Sanofi Aventis - speaker fee : Prasugrel
- Astra Zeneca - speaker fee : Rosuvastatin
- Chiesi - speaker fees : Rosuvastatin
D - Research funding (departmental or institutional). - Pfizer : Atorvastatin - Sanofi Aventis : Prasugrel
- Chiesi - speaker fees : Rosuvastatin
Danchin Nicolas Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Servier : antianginal agents - The Medicines Company : Antithrombotic agents
- BMS/Pfizer : Antithrombotic agents
- Boehringer Ingelheim : Antithrombotic agents
- Daiichi Sankyo, Eli-Lilly : Antithrombotic agents
- Sanofi-Aventis : antithrombotic agents, antiarrhythmic agents
- Astra-Zeneca : Antithrombotic agents, statins
- Novo-Nordisk : Diabetes
- Pierre Fabre : Omega 3
D - Research funding (departmental or institutional). - Merck : Myocardial infarction - Sanofi-Aventis : Myocardial infarction
- The Medicines Company : Myocardial infarction
- GSK : Myocardial infarction
- Astra-Zeneca : Myocardial infarction
- Daiichi-Sankyo Eli Lilly : Myocardial infarction
Guidelines on ACS-NSTE (TF21) - Document Reviewers
Expert Relationship with Industry
Type of relationship with industry Financial declaration
Falk Erling No
Goudevenos John A No
Gulba Dietrich Cl Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - The Medicines Company : Bivalirudin - Boehringer-Ingelheim : Dabigatran, rt-PA, TNK-tPA
- Sanofi Aventis : Enoxaparin
- Daiichi Sankyo : Prasugrel
- Eli Lilly : Prasugrel, abciximab
- Bayer Healthcare : Rivaroxaban
- Astra Zeneca : Ticagrelor
Hambrecht Rainer Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Berlin Chemie : ranolazine B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - pohl boskamp : nitrates
Herrmann Joerg No
Kastrati Adnan Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Abbott - lecture fees : DES B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Astra Zeneca : Antiplatelet - Lilly : Antiplatelet
- Biosensors : DES
- Cordis : DES
- Biotronic : DES
Kjeldsen Keld Per No
Kristensen Steen Dalby Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Daiichi Sankyo : Antithrombotics - Eli Lilly : Antithrombotics
Guidelines on ACS-NSTE (TF21) - Document Reviewers
Expert Relationship with Industry
Type of relationship with industry Financial declaration
Kristensen Steen Dalby Yes - Merck : Antithrombotics
- The Medicines Company : Antithrombotics
- AstraZeneca : Antithrombotics
Lancellotti Patrizio Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - ,astra zeneca, boheringer, menarini : pradaxa, belsar, crestor B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Actelion : tracleer
Mehilli Julinda Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Daiichi Sankyo - speaker fee : Antithrombotic drugs - Abbott - lecture fees : Stents
D - Research funding (departmental or institutional). - Abbott : Unrestricted grant for clinical studies - Terumo : Unrestricted grant for clinical studies
Merkely Bela Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Abbott, Biotronik, Boston Sci, Medtronic, Sanofi-Aventis, Servier, St. Jude : CRT implantation, ICD programing, education program, dronaderone, ivabradineB - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Abbott, Johnson & Johnson, Medtronic, : Xience V stent, education program
Montalescot Gilles Yes
B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Astra Zeneca - consulting or lecture fees : xy - Bayer - consulting or lecture fees : xy
- Boehringer Ingelheim - consulting or lecture fees : xy
- Cardiovascular Research Foundation - consulting or lecture fees : xy
- Cleveland Clinic Research Foundation - consulting or lecture fees : xy
- Daiichi Sankyo - consulting or lecture fees : xy
- Duke Institute - consulting or lecture fees : xy
- Eli Lilly - consulting or lecture fees : xy
Guidelines on ACS-NSTE (TF21) - Document Reviewers
Expert Relationship with Industry
Type of relationship with industry Financial declaration
Montalescot Gilles Yes - Europa - consulting or lecture fees : xy
- Lead-Up - consulting or lecture fees : xy
- GSK - consulting or lecture fees : xy
- Institut de Cardiologie de Montreal - consulting or lecture fees : xy
- Menarini - consulting or lecture fees : xy
- Nanospheres - consulting or lecture fees : xy
- Novartis - consulting or lecture fees : xy
- Pfizer - consulting or lecture fees : xy
- Portola - consulting or lecture fees : xy
- Sanofi Aventis - consulting or lecture fees : xy
- The Medicines Company - consulting or lecture fees : xy
- TIMI study group - consulting or lecture fees : xy
D - Research funding (departmental or institutional). - Astra Zeneca : xy - BMS : xy
- Boston Scientific : xy
- Eli Lilly : xy
- Medtronic : xy
- Pfizer : xy
- Servier : xy
- Sanofi Aventis : xy
- Abbott Vascular : xy
- Cordis : xy
- Fédération Française de Cardiologie : xy
- Fondation de France : xy
Guidelines on ACS-NSTE (TF21) - Document Reviewers
Expert Relationship with Industry
Type of relationship with industry Financial declaration
Montalescot Gilles Yes - Guerbet Medical : xy
- INSERM : xy
- ITC Edison : xy
- Société Française de Cardiologie : xy
- Stago : xy
Neumann Franz Josef Yes
B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Boston Scientific : devices - Medtronic : devices
- Cordis : devices
- Biotronic : devices
- Astra Zeneca : drugs
- The Medicines Company : drugs
- Lilly : drugs
- Siemens Healthcare : equipment
D - Research funding (departmental or institutional). - Boston Scientific : devices - Cordis : devices
- Metronic : devices
- Lilly : drugs
Neyses Ludwig Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Servier - speaker fees; investigator fees : Ivabradine D - Research funding (departmental or institutional). - Johnson & Johnson : Diagnostic use of metabolomics
Perk Joep Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Astra Zeneca - speaker fees : None specific
Guidelines on ACS-NSTE (TF21) - Document Reviewers
Expert Relationship with Industry
Type of relationship with industry Financial declaration
Perk Joep Yes B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Astra Zeneca : None specific
Pfisterer Matthias No
Roffi Marco Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Eli Lilly Lilly/Daiichi Sankyo - speakers fees; advisory board fees (prasugrel) : Antiplatelet therapy D - Research funding (departmental or institutional). - Abbott : devices - Boston Scientific : devices
- Cordis and Medtronic : devices
- Biotronik : devices
Romeo Francesco No
Ruda Mikhail Ya No
Swahn Eva Yes
D - Research funding (departmental or institutional). - Schering-Plough : Phase III study (TRACER)
Tavares Aguiar Carlos Manuel
Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Merck Sharp & Dohme - speaker fees : Niacin/Laropiprant - Menarini - speaker fees : Olmesartan
- Servier - speaker fees; investigator fees : Perindopril/Indapamide, Ivabradine
- Lilly - consultancy fees : Prasugrel
- Bayer - speaker fees; advisory board fees (rivaroxaban) : Rivaroxaban, Nifedipine, Telmisartan, Aspirin
- Astra Zeneca - speaker fees : Rosuvastatin
- Boehringer Ingelheim - speaker fees : Telmisartan
- Bial Portela - speaker fees : Valsartan/Amlodipine
Valgimigli Marco Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - The Medicines Company : bivalirudin - Terumo : Interventional cardiology
Guidelines on ACS-NSTE (TF21) - Document Reviewers
Expert Relationship with Industry
Type of relationship with industry Financial declaration
Valgimigli Marco Yes - Abbott Laboratories : ngal
- Accumetrics : Platlet Function Assay
- Roche Pharma : PPAR alpha/gamma
- Medtronic : stent
- Abbott Vascular : stent
- Cordis : stent
- CID : stent
- Astra Zeneca - consulting or lecture fees : ticagrelor
- Chiesi Pharma : tirofiban
- Iroko Cardio : Tirofiban
D - Research funding (departmental or institutional). - Abbott Laboratories : ngal
Vrints Christian Joseph Marie
Yes
B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Bayer : pharma D - Research funding (departmental or institutional). - Abbott : interventional cardiology - Medtronic : pacing
Widimsky Petr Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Servier : Antiischemic agents - Astra Zeneca : Antithrombotic agents
- Bayer : Antithrombotic agents
- Boehringer-Ingelheim : Antithrombotic agents
- Daiichi Sankyo : Antithrombotic agents
- Eli Lilly : Antithrombotic agents
- The Medicines Company : Antithrombotic agents
Guidelines on ACS-NSTE (TF21) - Document Reviewers
Expert Relationship with Industry
Type of relationship with industry Financial declaration
Widimsky Petr Yes - Duke University : Antithrombotic agents
- Abbott : Stents
- Boston Scientific : Stents
- Medtronic : Stents
Guidelines on ACS-NSTE (TF21) - Document Reviewers
Expert Relationship with Industry
Type of relationship with industry Financial declaration
ESC Committee for Practice Guidelines 2010-2012
ExpertRelationship
with IndustryType of relationship with industry Financial declaration
A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.YesAuricchio Angelo
- Biologics Delivery Systems, Cordis Corporation a Johnson & Johnson company : Biological Therapy
- Philips : Cardiac Imaging
- Merck : Drugs
- Biotronik : Implantable Cardiac Electronic Device
- EBR Systems : Implantable Cardiac Electronic Device
- Impulse Dynamics : Implantable Cardiac Electronic Device
- Medtronic : Implantable Cardiac Electronic Device
- Sorin : Implantable Cardiac Electronic Device
- St. Jude Medical : Implantable Cardiac Electronic Device
- Abbott : Implantable Cardiac Electronic Device
A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.YesBaumgartner Helmut
- Actelion : Bosentan for PAH treatment in congenital heart disease
- AGA : Devices for catheter treatment of congenital heart defects
B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.
- Edwards Lifesciences : transcatheter valve implantation
A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.YesBax Jeroen
- Heart.org : Education
- Servier : Farma
- Astra Zeneca : Farma
- GE Healthcare : Imaging
- Lantheus : Imaging
- Philips : Imaging
- St Jude Medical : Pacing
ESC Committee for Practice Guidelines 2010-2012
ExpertRelationship
with IndustryType of relationship with industry Financial declaration
- Medtronic : Pacing
- Impulse Dynamics : Pacing
- Biotronik : Pacing
- Boston Scientific : Pacing
D - Research funding (departmental or institutional).YesBax Jeroen
- Servier : Farma
- Edwards Lifesciences : Heart Valves
- Lantheus : Imaging
- GE Healthcare : Imaging
- Boston Scientific : Pacing
- Medtronic : Pacing
- St Jude Medical : Pacing
- Biotronik : Pacing
A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.YesCeconi Claudio
- Servier : Pharmaceutical
A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.YesDeaton M Christi
- St Jude Ltd : Cath lab - speaker X 1
- Daiichi Sankyo : consultant for patient adherence 2009-10
- Eli Lilly : consultant for patient adherence 2009-10
D - Research funding (departmental or institutional).
- Novo Nordisk : medicines for diabetes
A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.YesFagard Robert
- Servier : perindopril; support for organisation of scientific meeting
A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.YesFunck-Brentano Christian
- Pierre-Fabre : Cardiac Safety of non-cardiovasclar products
ESC Committee for Practice Guidelines 2010-2012
ExpertRelationship
with IndustryType of relationship with industry Financial declaration
- Servier : Cardiac safety of non-cardiovascular drugs under development or on the market. Design of phase I/II trials.
- Johnson & Johnson : Cardiac safety of non-cardiovascular drugs under development or on the market. Design of phase I/II trials.
- Sigma-Tau (Italy) : Cardiac Saftey of an antimalarial drug
- Santhera (CH) : Cardiac Saftey of an antimalarial drug
- MMV (CH) : Cardiac Saftey of an antimalarial drug
- TROPHOS : DSMB for an investigational drug in Amyotrophic Lateral Sclerosis – Cardiac safety
- CEPHALON : DSMB in an oncology phase IIb trial
- Jansen-Cilag : Proton-pump inhibitors and drug interactions, including Clopidogrel
D - Research funding (departmental or institutional).YesFunck-Brentano Christian
- Jansen-Cilag : Proton-pump inhibitors and drug interactions with Clopidogrel
A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.YesHasdai David
- Sanofi Aventis : Enoxaparin
D - Research funding (departmental or institutional).YesHoes Arno
- Bayer Healthcare : unresctricted grant for diagnostic kits in suspected cardiovascualar disease
- Abbott Laboratories : unresctricted grant for diagnostic kits in suspected cardiovascualar disease
- Roche : unresctricted grant for diagnostic kits in suspected heart failure and acute coronary syndrome
A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.YesKnuuti Juhani
- Lantheus Inc : Imaging tracers
D - Research funding (departmental or institutional).
- Bayer : Development of imaging agents
- GE Healthcare : Development of imaging agents
- Lantheus : Development of imaging agents
- Novartis : Development of imaging agents
- Roche : Drugs for brain diseases
A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.YesKolh Philippe H
ESC Committee for Practice Guidelines 2010-2012
ExpertRelationship
with IndustryType of relationship with industry Financial declaration
- Merck Sharp & Dohme : Antiarrhythmic agents
- Bristol Myers Squibb : Antiplatelet agents
- Astra Zeneca : Antiplatelet agents
- Regado Biosciences : Antithrombotic agents
- Abbott - lecture fees : coronary stents
B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.YesKolh Philippe H
- Merck Sharp & Dohme : Antistaphylococcic vaccine
D - Research funding (departmental or institutional).
- Edwards Lifesciences : Cardiac valves
- Medtronic : Cardiac valves
- St Jude Medical : Cardiac valves
- Siemens Healthcare : Imaging
- Johnson & Johnson : Thoracoscopic devices
A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.YesMcDonagh Theresa
- Vifor International : Ferrinject
B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.
- Servier - speaker fee : Ivabridine
D - Research funding (departmental or institutional).
- Biotronik - Clinical Trial : CRT
D - Research funding (departmental or institutional).YesPoldermans Don
- Maquette : Balloon pump device
- Merck : drugs
- Novartis : drugs
- Baxter : drugs
- Medtronic : Reveal device
ESC Committee for Practice Guidelines 2010-2012
ExpertRelationship
with IndustryType of relationship with industry Financial declaration
A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.YesPopescu Bogdan Alexandru
- GE Healthcare : Imaging
A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.YesReiner Zeljko
- Bayer Healthcare : anticoagulants
- Abbott - lecture fees : antilipemics
- Astra Zeneca : antilipemics
- Merck Sharp & Dohme : antilipemics
- Pfizer : antilipemics
A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.YesSechtem Udo
- Boehringer Ingelheim : Anticoagulation
- Daiichi Sankyo : Antiplatelet therapy
- Novartis : Drugs
- General Electric : Imaging
- Siemens Healthcare : Imaging
B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.
- Novartis : Imaging devices
- Johnson & Johnson : Stents
D - Research funding (departmental or institutional).YesSirnes Per Anton
- Bayer : clinical studies atrial fibrillation investigator fee
- Johnson & Johnson : inestigator fee, ckinical study, atrial fibrillation
- MSD : investgator fee clinical studies hyperlipidemia, SCAD
- Glaxo Smith Kline : investigator fee, clinical study , SCAD
- Servier : investigator fee, clinical study, coronary artery disease
- Jansen-Cilag : investigator fee, clinical study, diabetes CVD
- Boehringer Ingelheim : investigator fee, clinicla study, AF
ESC Committee for Practice Guidelines 2010-2012
ExpertRelationship
with IndustryType of relationship with industry Financial declaration
A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.YesTorbicki Adam
- Boehringer-Ingelheim : anticoagulation
- Sanofi Aventis : anticoagulation
- Pfizer : anticoagulation, pulmonary hypertension
- Lilly : pulmonary hypertension
- Actelion : pulmonary hypertension
- Bayer Healthcare : pulmonary hypertension, anticoagulation
A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.YesVahanian Alec
- Boehringer Ingelheim : Valve prostheses
- Siemens Healthcare : Valve prostheses
- Valtech : Valve prostheses
- Edwards Lifesciences : Valve prostheses
- Abbott : Valve prostheses
- Medtronic - Advisory Board : Valve prostheses
A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.YesWindecker Stephan
- Astra Zeneca : Antiplatelet drug
- Eli Lilly : Antiplatelet drug
- Abbott : Stent
- Biosensors : Stent
- Biotronik : Stent
- Boston Scientific : Stent
- Cordis : Stent
- Medtronic : Stent
D - Research funding (departmental or institutional).
- Medtronic : Stent
ESC Committee for Practice Guidelines 2010-2012
ExpertRelationship
with IndustryType of relationship with industry Financial declaration
- Abbott : Stent
- Biosensors : Stent
- Cordis : Stent
This table represents the relevant relationships of the above experts with Industry and other entities that were reported to us at the time of publication of the guidelines.
Top Related